asthma – Discover Pharma

Welcome to Discover Pharma! Today is : June 11, 2026

asthma

Drug Delivery & Formulation,Medical devices,Pharmaceuticals and therapeutics
Nebu~Flow secures £2M Scottish Enterprise grant for nebuliser technology
Glasgow medical technology company Nebu~Flow has secured a £2 million [...]

June 8, 2026
Central Nervous System,Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas
Positive Phase 3 KALOS and LOGOS trial results for Breztri published in The Lancet Respiratory Medicine
Full results from the Phase 3 KALOS and LOGOS trials [...]

May 5, 2026
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
GSK’s depemokimab backed by Phase 3 data ahead of FDA decision in asthma and sinusitis
Phase 3 data for GSK’s depemokimab appear to support the [...]

May 5, 2026
Digital & Data,Drug Discovery & Development,Medical devices,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas
electronRx to launch app for remote respiratory disease management
electronRx will launch its pDx app at the HLTH 2025 [...]

May 5, 2026
Advanced Therapies,Drug Discovery & Development,Opinion & Events
Ethris begins Phase 2a trial of intranasal mRNA candidate ETH47 for virus-triggered asthma
Ethris has dosed the first patient in a Phase 2a [...]

May 5, 2026

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK